Preview Mode Links will not work in preview mode

Mar 2, 2022

Featuring perspectives from Drs Neeraj Agarwal, Himisha Beltran, Fred Saad and A Oliver Sartor, moderated by Dr Alan Bryce, including the following topics:

  • Introduction (0:00)
  • Optimal Use of Hormonal Therapy in Nonmetastatic Prostate Cancer (PC) and Metastatic Hormone-Sensitive Disease — Fred Saad, MD (4:18)
  • Selection and Sequencing of Therapy for Patients with Metastatic CRPC (mCRPC) — A Oliver Sartor, MD (29:57)
  • Integration of PARP Inhibitors into the Current Management of mCRPC — Himisha Beltran, MD (53:42)
  • Available Data with, Ongoing Investigation of and Potential Future Role of PARP Inhibitor-Based Combinations — Alan H Bryce, MD (1:18:49)
  • Novel Investigational Strategies for Patients with PC — Neeraj Agarwal, MD (1:44:48)

CME information and select publications